Prostate cancer
RecruitingStudy on Shortened Treatment with Apalutamide and Enzalutamide for Patients with Low-Volume Metastatic Castration-Sensitive Prostate Cancer
Study on Shortened Treatment with Apalutamide and Enzalutamide for Patients with Low-Volume Metastatic Castration-Sensitive Prostate Cancer
- Disease:Prostate cancer
- Substances:ApalutamideEnzalutamide+4
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Apalutamide
- Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)










